An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
![](https://jonathanhaverkampf.com/wp-content/uploads/2022/09/NYT_logo_rss_250x40.png)
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.